EFFECT OF CONTINUOUS SPINAL REMIFENTANIL INFUSION ON BEHAVIOR AND SPINAL GLUTAMATE RELEASE EVOKED BY SUBCUTANEOUS FORMALIN IN THE RAT

Citation
H. Buerkle et al., EFFECT OF CONTINUOUS SPINAL REMIFENTANIL INFUSION ON BEHAVIOR AND SPINAL GLUTAMATE RELEASE EVOKED BY SUBCUTANEOUS FORMALIN IN THE RAT, British Journal of Anaesthesia, 80(3), 1998, pp. 348-353
Citations number
33
Categorie Soggetti
Anesthesiology
ISSN journal
00070912
Volume
80
Issue
3
Year of publication
1998
Pages
348 - 353
Database
ISI
SICI code
0007-0912(1998)80:3<348:EOCSRI>2.0.ZU;2-Q
Abstract
Injection of formalin into the hind paw of the rat evokes a biphasic n ociceptive behavioural response, which is considered to be an animal m odel of postoperative pain in humans. The initial response (phase 1) i s caused by activation of peripheral nociceptors and is followed by a second phase attributed to ongoing activity in primary afferents and i ncreased sensitivity of dorsal horn neurones. The latter effect is tho ught to result from glutamate-mediated N-methyl-D-aspartate receptor a ctivation. In studies to date it has been difficult to discriminate me chanisms underlying phase 1 and phase 2 events because of the long-las ting half-times of intrathecally administered opioids. To further unde rstanding of the opioid pharmacology of the two different phases of th e formalin test, we have studied behavioural activity and spinal gluta mate release after intrathecal administration of remifentanil, a new s hort-lasting mu opioid. Intrathecal remifentanil 3 mu g mu l(-1) min(- 1) delivered during phase 1 inhibited behavioural response during phas e 1 (100%), but did not abolish subsequent phase 2 behavioural activit y completely (67 (12) %). Intrathecal remifentanil administered separa tely in phase 1 and phase 2 revealed a similar ED50 (0.2 mu g mu l(-1) min(-1)) for inhibition of the behavioural responses. In vivo, spinal microdialysis showed incomplete reduction in glutamate concentrations in response to intrathecal remifentanil administration; this in turn inhibited phase 1 behavioural responses. Therefore we contend that sup ramaximal doses of intrathecal remifentanil sufficient to inhibit phas e 1 activity still permitted sufficient glutamate release to allow spi nal facilitation. Incomplete suppression of spinal excitatory neurotra nsmitter release by intrathecal opioids is consistent with spinal wind -up that is triggered during phase 1 and results in phase 2 afferent d rive. This might reflect one of the mechanisms underlying postoperativ e pain.